LLY

704.71

+0.12%↑

JNJ

178.66

+0.51%↑

ABBV

208.68

+1.3%↑

UNH

299.83

-1.31%↓

AZN

80.53

+1.23%↑

LLY

704.71

+0.12%↑

JNJ

178.66

+0.51%↑

ABBV

208.68

+1.3%↑

UNH

299.83

-1.31%↓

AZN

80.53

+1.23%↑

LLY

704.71

+0.12%↑

JNJ

178.66

+0.51%↑

ABBV

208.68

+1.3%↑

UNH

299.83

-1.31%↓

AZN

80.53

+1.23%↑

LLY

704.71

+0.12%↑

JNJ

178.66

+0.51%↑

ABBV

208.68

+1.3%↑

UNH

299.83

-1.31%↓

AZN

80.53

+1.23%↑

LLY

704.71

+0.12%↑

JNJ

178.66

+0.51%↑

ABBV

208.68

+1.3%↑

UNH

299.83

-1.31%↓

AZN

80.53

+1.23%↑

Search

Avalo Therapeutics

Suletud

9.21 6.11

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

8.25

Max

9.21

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+262.81% upside

Avalo Therapeutics Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

20. aug 2025, 23:09 UTC

Tulu

Brambles Lifts Fiscal Year Profit 10%, Launches Fresh US$400 Million Buyback -- Update

20. aug 2025, 22:53 UTC

Tulu

AIA Posts Record New Business in 1st Half, Boosts Dividend

20. aug 2025, 22:45 UTC

Tulu

Brambles Lifts Fiscal Year Profit 10%, Launches Fresh US$400 Million Buyback

20. aug 2025, 22:32 UTC

Tulu

Goodman Targets 9% Earnings Growth in Fiscal Year 2026

20. aug 2025, 23:52 UTC

Market Talk

Global Equities Roundup: Market Talk

20. aug 2025, 23:52 UTC

Market Talk

Goodman Likely Conservative Again With Earnings Outlook -- Market Talk

20. aug 2025, 23:40 UTC

Market Talk

Nikkei May Decline After U.S. Tech Stocks Drop -- Market Talk

20. aug 2025, 22:54 UTC

Tulu

Brambles Lifts FY Profit 10%, Launches Fresh US$400M Buyback -- Update

20. aug 2025, 22:48 UTC

Omandamised, ülevõtmised, äriostud

Doosan: Asset Sales Aimed at Securing Capital to Invest in Core Businesses

20. aug 2025, 22:47 UTC

Omandamised, ülevõtmised, äriostud

Doosan: HD Korea Shipbuilding & Offshore Engineering to Buy Full Stake in Doosan Vina for $210M

20. aug 2025, 22:38 UTC

Tulu

AIA Posts Record New Business in 1H, Boosts Dividend

20. aug 2025, 22:30 UTC

Tulu

Brambles Lifts FY Profit 10%, Launches Fresh US$400M Buyback

20. aug 2025, 22:28 UTC

Tulu

Brambles: More Manufacturers Are Switching to Pooled Pallets>BXB.AU

20. aug 2025, 22:27 UTC

Tulu

Brambles: Tariff-Related Concerns Hit 2H Volume Growth>BXB.AU

20. aug 2025, 22:27 UTC

Tulu

Brambles: Growth With New Customers More Than Offset Volume Headwinds>BXB.AU

20. aug 2025, 22:24 UTC

Tulu

AIA Group Recommends Interim Dividend of 49.00 Hong Kong Cents/Share >1299.HK

20. aug 2025, 22:24 UTC

Tulu

AIA Group 1H Value of New Business Margin Was 57.7%, Up 3.4 Ppt on Year >1299.HK

20. aug 2025, 22:22 UTC

Tulu

AIA Group 1H Value of New Business $2.84B Vs. $2.46B >1299.HK

20. aug 2025, 22:17 UTC

Tulu

Goodman Targets 9% Earnings Growth in FY 2026

20. aug 2025, 22:16 UTC

Tulu

Brambles Completed $403M of Buybacks in FY 2025>BXB.AU

20. aug 2025, 22:16 UTC

Tulu

Brambles Announces New $400M on-Market Share Buyback>BXB.AU

20. aug 2025, 22:15 UTC

Tulu

Brambles: FY 2026 Guidance Excludes Currency Moves>BXB.AU

20. aug 2025, 22:14 UTC

Tulu

Brambles Expects FY 2026 Free Cash Flow Before Dividends of $850M-$950M>BXB.AU

20. aug 2025, 22:14 UTC

Tulu

Brambles Expects FY 2026 Underlying Profit Growth of 8-11%>BXB.AU

20. aug 2025, 22:14 UTC

Tulu

Brambles Expects FY 2026 Revenue Growth of 3-5%>BXB.AU

20. aug 2025, 22:13 UTC

Tulu

Brambles FY Post-Tax Operating Profit $864.2M, Up 13% Ex-Currency Moves>BXB.AU

20. aug 2025, 22:13 UTC

Tulu

Brambles FY Free Cash Flow Before Dividends $1.09B Vs. $883M>BXB.AU

20. aug 2025, 22:12 UTC

Tulu

Goodman FY 2025 Operating EPS Up 9.8%

20. aug 2025, 22:12 UTC

Tulu

St Barbara: FY Realized Gold Price from Continued Operations A$4,428/oz

20. aug 2025, 22:12 UTC

Tulu

Goodman Expects FY 2026 Operating EPS Growth of 9%

Võrdlus sarnastega

Hinnamuutus

Avalo Therapeutics Prognoos

Hinnasiht

By TipRanks

262.81% tõus

12 kuu keskmine prognoos

Keskmine 32.29 USD  262.81%

Kõrge 48 USD

Madal 15 USD

Põhineb 6 Wall Streeti analüütiku instrumendi Avalo Therapeutics 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

6 ratings

6

Osta

0

Hoia

0

Müü

Finantsandmed

$